XML 37 R26.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Insider Trading Arrangements
 3 Months Ended
Mar. 31, 2024
shares
Trading Arrangements, by Individual  
Non-Rule 10b5-1 Arrangement Adopted false
Rule 10b5-1 Arrangement Terminated false
Non-Rule 10b5-1 Arrangement Terminated false
Steven Stein [Member]  
Trading Arrangements, by Individual  
Material Terms of Trading Arrangement
Steven Stein, our Executive Vice President and Chief Medical Officer, adopted a trading plan on February 20, 2024 providing for the sale of up to an aggregate of 20,147 shares of our common stock until December 31, 2024.
Name Steven Stein
Title Executive Vice President and Chief Medical Officer
Rule 10b5-1 Arrangement Adopted true
Adoption Date February 20, 2024
Arrangement Duration 315 days
Aggregate Available 20,147
Barry Flannelly [Member]  
Trading Arrangements, by Individual  
Material Terms of Trading Arrangement
Barry Flannelly, our Executive Vice President and General Manager, North America, adopted a trading plan on February 20, 2024 providing for the sale of up to an aggregate of 52,931 shares of our common stock until December 31, 2024.
Name Barry Flannelly
Title Executive Vice President and General Manager, North America
Rule 10b5-1 Arrangement Adopted true
Adoption Date February 20, 2024
Arrangement Duration 315 days
Aggregate Available 52,931
Thomas Tray [Member]  
Trading Arrangements, by Individual  
Material Terms of Trading Arrangement
Thomas Tray, our Vice President, Chief Accounting Officer, adopted a trading plan on March 7, 2024 providing for the sale of up to an aggregate of 1,093 shares of our common stock until June 28, 2024.
Name Thomas Tray
Title Vice President, Chief Accounting Officer
Rule 10b5-1 Arrangement Adopted true
Adoption Date March 7, 2024
Arrangement Duration 113 days
Aggregate Available 1,093